Sept 25 (Reuters) – The US Food and Drug Administration has approved AbbVie's drug for Parkinson's disease in adults, the health regulator's website showed on Friday. (Reporting by Kamal Choudhury in
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: PRESS CONFERENCE WITH SPAIN MIDFIELDER RODRI, WITH COMMENTS ON MANCHESTER CITY AND THE…
Sept 25 (Reuters) - TikTok and its Chinese parent company, ByteDance, have reached a settlement…
By Alexandra Alper WASHINGTON, Sept 25 (Reuters) - A bipartisan group of US lawmakers introduced legislation…
(Adds analyst comment in paragraphs 3-4) Sept 25 (Reuters) - Insurance underwriter TFP Group, better…
Sept 25 (Reuters) - TikTok and its Chinese parent company, ByteDance, have reached a settlement…
Sept 25 (Reuters) - TikTok and its Chinese parent company, ByteDance, have reached a settlement…